-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly Revenues history and growth rate from Q2 2022 to Q3 2024.
- Arcutis Biotherapeutics, Inc. Revenues for the quarter ending September 30, 2024 was $44.8M, a 17.4% increase year-over-year.